An Indian company that says it supplies ingredients for major drugmakers was warned by U.S. regulators for forging test results and failing to properly clean equipment.
The Food and Drug Administration is stepping up enforcement in India where growing quality concerns have led the agency to ban U.S. sales from some factories. Canton Laboratories Private Ltd. of Vadodara, India, was warned in a letter dated Feb. 27 for a variety of manufacturing practices, including reporting results for tests it never performed to measure microorganisms in active ingredients and failing to ensure equipment was cleaned to prevent contamination.
